Demaria, Sandra http://orcid.org/0000-0003-4426-0499
Romano, Emanuela
Brackstone, Muriel
Formenti, Silvia C.
Funding for this research was provided by:
National Cancer Institute (R01 CA198533, R01CA201246)
Breast Cancer Research Foundation (BCRF-18-053)
The Chemotherapy Foundation (N/A)
U.S. Department of Defense (BC180476)
Article History
Received: 15 July 2019
Accepted: 22 October 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare no competing financial interests related to this manuscript, but SCF has received advisory/ speaker compensation from Sanofi, Regeneron, Elekta, EMD Serono, Merck, Astra Zeneca, Bayer and research support from Varian, Bristol-Myer Squibb, Regeneron, Eisai, Merck and Janssen, SD has received compensation for consultant/advisory services from Lytix Biopharma, AstraZeneca, Mersana Therapeutics and EMD Serono, and research support form Lytix Biopharma and Nanobiotix, and ER has received research funding from Bristol-Myer Squibb.